Drug Search Results
More Filters [+]

AB-126

Alternative Names: AB-126, AB126, AB 126
Latest Update: 2024-06-05
Latest Update Note: News Article

Product Description

Aruna is developing AB-126 as a treatment for neurological conditions. (Sourced from: https://www.arunabio.com/ab126intro)

Mechanisms of Action: Stem Cell Therapy

Novel Mechanism: Yes

Modality: Cell Therapy

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Aruna
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for AB-126

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 0: Ischemic Stroke

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events